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Takayasu’s arteritis is a rare, chronic inflammatory and stenotic dis­
ease of medium­ and large­sized arteries, characterised by a predilec­
tion for the aortic arch and its branches.[1,2] It is predominantly a dis­
ease of young adults in the second and third decades of life. However, 
its onset can be earlier in childhood,[3] and cases have been described 
in infants.[4­6] The inflammatory nature of the disease results in a wide 
range of vascular lesions including varying degrees of arterial steno­
sis, occlusion or aneurysmal dilation of the involved vessels. Stenosis 
often results in visceral ischaemia, and the disease frequently affects 
the kidney.[7,8]
Involvement of the renal arteries is fairly common in children[1,7­9] 
and is associated with severe hypertension and chronic kidney 
disease, with consequent significant morbidity and mortality. In 
previous studies from South Africa (SA), the renal arteries were 
affected in 78 ­ 86% of cases.[7,9] Kidney revascularisation procedures 
are often required to control hypertension or to salvage renal 
function.
Reports on renal function outcomes of revascularisation proce­
dures in children and adults are scarce and poorly reported. 
Differences in the disease pattern between children and adults,[10] as 
well as the fact that children are still growing, may affect the outcome 
of interventions, necessitating studies in children. We recently 
reported on the outcome of hypertension in a cohort of patients 
with Takayasu’s arteritis, but did not adequately report on their renal 
function outcomes.[11] Owing to the progressive nature of the disease, 
renal function may continue to deteriorate despite adequate blood 
pressure control.
Objective
To determine the salvageability of renal function following re vascu­
larisation procedures in the same cohort of children with Takayasu’s 
arteritis­induced renal artery stenosis (TARAS) in our centre.
Methods
This was a 21­year retrospective review of the database of all chil­
dren with TARAS who had renal artery revascularisation procedures 
between 1 January 1990 and 31 December 2010 at Red Cross War 
Memorial Children’s Hospital, Cape Town, SA. The hospital is a 
tertiary referral centre that provides specialist care to all children from 
referral regions of the Western Cape and Eastern Cape provinces. 
Diagnosis of Takayasu’s arteritis was based on the European League 
Against Rheumatism/Paediatric Rheumatology European Society 
(EULAR/PReS) endorsed consensus criteria for the classification of 
childhood vasculitides,[12] and on the Ishikawa criteria[13] before the 
year 2006. Renal artery stenosis, usually determined using Doppler 
ultrasonography and computed tomography angiography, is defined 
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Background. Renal artery revascularisation procedures are usually carried out on children with renal artery stenosis from varied causes, 
including Takayasu’s arteritis. Reports on the outcome of such procedures in children usually refer to the improvement in blood pressure, 
with only minimal mention of effects on renal function.
Objective. Salvageability of renal function in children who underwent renal revascularisation for Takayasu’s arteritis­induced renal artery 
stenosis (TARAS) was the focus of this study.
Methods. We undertook a retrospective analysis of children aged ≤16 years with angiographically confirmed TARAS who underwent renal 
artery revascularisation procedures between 1990 and 2010. Outcomes of renal function were studied over a period of 2 years and were 
defined as: (i) improvement: >20% increase in estimated glomerular filtration rate (e­GFR) from presurgery value; (ii) stabilisation: e­GFR 
within 20% of presurgery value; and (iii) failure: >20% deterioration in e­GFR from presurgery value. The GFR was estimated using the 
Schwartz formula.
Results. Twenty children (9 males and 11 females, age range 2 ­ 14 years) had 27 renal artery revascularisation procedures. Thirteen of the 
patients (65.0%) had bilateral renal artery stenosis. The baseline mean e­GFR was 88.6 (standard deviation (SD) 25.4) mL/min/1.73 m2 
and the mean duration of follow­up was 28.80 (SD 25.62) months. All the patients had stable or improved renal function until the 2­year 
follow­up, when the proportion decreased to 92.3% (12/13), as failure was recorded in one child. Bilateral revascularisation was found to be 
significantly associated with improvement in renal function in the early postoperative period (p=0.04).
Conclusion. Renal artery revascularisation procedures are successful in salvaging renal function in children with TARAS.
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RESEARCH
814       August 2016, Vol. 106, No. 8
as stenosis of the main renal artery or its proximal branches and is 
considered significant if >50% of the lumen is involved.
Children diagnosed with Takayasu’s arteritis are managed by 
a multidisciplinary team comprising the paediatric nephrology, 
rheumatology and surgical units. All children were initially managed 
based on the hospital’s standard medical management protocol, 
which includes: (i) antituberculosis treatment for 6 months with 
three drugs (as there is an extremely high prevalence of tuberculosis 
in the hospital drainage area, associated with a positive tuberculin 
skin test in >90% of our patients with Takayasu’s arteritis[11]); 
(ii) immunosuppression with pulse methylprednisolone (followed 
by daily oral prednisone, which is gradually tailed off over 2 ­ 
3  months), a single dose of intravenous cyclophosphamide at 
500 ­ 750 mg/m2, and oral methotrexate at 10 ­ 15 mg/m2/week; and 
(iii) anti hypertensives as indicated.
Following acute reduction in disease activity, as determined by the 
absence of signs and symptoms of systemic disease such as fever and 
malaise, as well as normalisation of the erythrocyte sedimentation 
rate (ESR), surgical procedures are performed for children with 
refractory hypertension (unresolved hypertension after 3 months on 
at least three antihypertensive drugs from different classes, including a 
diuretic[14]), severe side­effects of medication, medication intolerance 
and/or deterioration in renal function as determined by serum 
creatinine (sCr) and glomerular filtration rate (GFR) estimations and 
aneurysms. The surgical procedures performed include percutaneous 
transluminal angioplasty (PTA), kidney autotransplantation, arterial 
bypass surgery using either autologous or prosthetic vascular grafts, 
or revascularisations using splenic, hepatic and other arteries. Some 
children also had a nephrectomy.
Criteria for success were adopted from the American Heart 
Association guidelines for reporting of renal artery revascularisation 
in clinical trials.[15] Renal function was monitored using serial sCr 
levels and estimated glomerular filtration rates (eGFRs). The GFR 
was estimated using the modified Schwartz formula (eGFR corrected 
for gender and age).[16] The baseline sCr concentration was taken 
to be the level closest to the date of operation, all within 1 week of 
surgery. Subsequent sCr concentrations to document renal function 
response were recorded at 2 weeks ­ 3 months, 3 ­ 6 months, 6 ­ 12 
months and 12 ­ 24 months after surgery. The renal response to 
revascularisation was assessed as follows: (i) improvement: >20% 
increase in e­GFR from presurgery value; (ii) stabilisation: e­GFR 
within 20% of presurgery value; and (iii) failure: >20% deterioration 
in e­GFR from presurgery value.
Ethical considerations
As this was a review of a database, all patient records were anony­
mised and deidentified prior to analysis. This retrospective study was 
approved by the Human Research Ethics Committee of the Faculty 
of Health Sciences, University of Cape Town (HREC Ref.: 026/2013).
Statistical analysis
All data were analysed using SPSS 20.0 software (IBM, USA). 
Continu ous data were presented as means (standard deviations 
(SDs)). Differ ences in continuous data were analysed with Student’s 
t­test, while those for categorical data were analysed using the χ2 test. 
A p­value of <0.05 was considered to be statistically significant in all 
analyses.
Results
Fifty­nine children with Takayasu’s arteritis were managed during 
the 21­year study period. Of these, 20 (34.0%), with ages ranging 
between 2 and 14 years, had renal artery revascularisation for 
TARAS. All of them were significantly hypertensive. Of the children 
who had revascularisation surgery, 13 (65.0%) had bilateral renal 
artery stenosis. The mean duration of follow­up was 28.80 (SD 25.62) 
months (range 1 ­ 81). Demographic data and laboratory values for 
the children who had revascularisation surgery are shown in Table 1. 
No child was on renal replacement therapy.
Renal function outcomes
The 20 children underwent 27 revascularisation procedures. Six of 
the children had bilateral revascularisation for significant bilateral 
disease. Of these 6, 1 had another revascularisation procedure carried 
out on one side because of a previously unsuccessful procedure. The 
remaining 7 children who had bilateral disease had revascularisation 
procedures carried out on the side with the more significant stenosis. 
Four children had undergone nephrectomy before revascularisation, 
while 3 had nephrectomy done after the revascularisation surgery. 
All but 1 of the children had the revascularisation carried out in our 
facility. The commonest procedure was PTA, which was done singly 
or in combination with other procedures in 10 patients (50.0%). 
The procedures done were as follows: (i) PTA: 10 patients; (ii) auto­
transplants: 9 patients; (iii) revascularisations using splenic and 
hepatic arteries: 6 patients; and (iv) arterial bypasses with autologous 
grafts: 2 patients.
Renal function outcomes were available for 17 (85.0%), 17 (85.0%), 
14 (70.0%) and 13 (65.0%) patients at the 3­month, 6­month, 
1­year and 2­year follow­up periods, respectively. Five children had 
returned to the regions from which they had been referred – 1 to 
another country and 4 to other regions within SA. Within the first 
3 months after revascularisation, 8/17 patients (47.1%) experienced 
Table 1. Demographic and laboratory variables for children 
who underwent revascularisation surgery for TARAS (N=20)
Variable Value
Age (years), mean (SD) 9.1 (3.1)
Gender, n (%)
Males 9 (45.0)
Females 11 (55.0)
Hypertension, n (%) 20 (100.0)
Baseline ESR (mm/h), range (median) 5 ­ 143 (52.9)
Baseline sCr (µmol/L), range, mean (SD) 53 ­ 150, 88.6 (25.4)
Side of renal artery stenosis, n (%)
Right 5 (25.0)
Left 2 (10.0)
Bilateral 13 (65.0)
Table 2. Mean eGFR values at different follow-up periods
Period under review Patients, n
eGFR values (mL/
min/1.73 m2), mean (SD)
Before revascularisation 20 88.6 (25.4)
After revascularisation
0 ­ 3 months 17 101.4 (24.7)
3 ­ 6 months 17 98.3 (19.5)
6 ­ 12 months 14 98.8 (24.5)
12 ­ 24 months 13 95.2 (22.7)
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an improvement in their renal function, with 9 (52.9%) remaining 
stable. By 6 months, 9/17 patients (52.9%) had improved renal 
function, the renal function of the remaining 8 patients (47.1%) 
remaining essentially unchanged. Subsequent evaluations at 1 and 
2 years after revascularisation showed improvement in 6/14 (42.9%) 
and 5/13 (38.5%) patients, respectively, while deterioration in renal 
function was recorded in 1 patient (7.7%) at the 2­year follow up. All 
the other children had stable renal function. Ninety­two percent of 
the patients therefore had stable or improved renal function at long­
term follow­up (p<0.05).
The mean (SD) eGFR values at the various follow­up periods 
are shown in Table 2. There was no significant association between 
age, sex, type of revascularisation procedure, number of anti­
hypertensive medications or blood pressure control and renal 
outcome of revascularisation at the various follow­up periods (p>0.05 
at each period). However, bilateral revascularisation was found to be 
significantly associated with an improvement in renal function in the 
early 3­month postoperative period (p=0.04). This significance was 
not observed at further longer­term follow­up periods.
Discussion
Revascularisation procedures have increasingly been used in 
the management of renal artery stenosis refractory to medical 
management. There are few reports on the efficacy of renal artery 
revascularisation in salvaging renal function in children with renal 
artery stenosis from various causes, including Takayasu’s arter­
itis. [17­23] In fact, before the report by Piercy et al.,[19] there were no 
articles reporting on changes in estimated GFR, as is the currently 
accepted norm.[15,20­22] Prior to this, renal function was often reported 
as the mean of absolute sCr values or as a function of the number 
of patients with chronic kidney disease. This gives no indication of 
the success or failure of the intervention in salvaging renal function.
There is in fact only one report on children with Takayasu’s 
arteritis that reported on renal function after revascularisation. [21] 
In 33 children, Feng et al.[21] demonstrated an improvement in 
e­GFR in 36%, stabilisation in 52% and failure in only 4%. This was 
similar to our group of children with TARAS, almost all of whom 
had improved or stable renal function on follow­up, with only one 
child exhibiting deterioration in renal function on long­term follow­
up. Other studies from the USA[19,24] and the UK[20,25] have shown 
similar findings of salvageable renal function following surgical 
procedures in patients with renal artery stenosis, with much higher 
rates of success but mainly in diseases other than Takayasu’s arteritis. 
In adults with Takayasu’s arteritis, as reported by Weaver et al.,[26] 
renal revascularisation resulted in the improvement or stabilisation 
of renal function in almost all the patients studied, including 
reversing the dialysis dependence of 2 of the 3 patients who were 
dialysis dependent preoperatively. Similar findings were reported 
by Ham et al.,[27] who studied adults with non­atherosclerotic renal 
artery disease and found significant improvement in renal function, 
especially in those with Takayasu’s arteritis.
Monitoring and reporting on renal function is vital, and small 
changes in GFR could alert the practitioner to the possibility of 
progressive disease that may warrant further imaging and possible 
intervention. A child could have deteriorating renal function while his 
or her blood pressure is controlled on antihypertensive medications. 
Children with Takayasu’s arteritis, as opposed to adults, often 
have active disease that may progress. Patients with active disease 
have been shown in several studies to have worse outcomes after 
surgical intervention.[21,28,29] It is therefore important to monitor their 
renal function regularly to detect any deterioration. In their series, 
Stanley et al.[24] reported no case of potential worsening of renal 
function despite the loss of renal mass associated with nephrectomy, 
which was carried out in a number of their cases. This is similar 
to our findings in the cases in which nephrectomy was done. It 
probably emphasises the known fact that a well­perfused kidney 
will compensate for lack of function on the other side, and further 
stresses the importance of monitoring for small changes in GFR. In 
our centre, we have started performing nuclear medicine studies with 
individualised GFR measurements to monitor the GFR of individual 
kidneys. This is because absolute creatinine values alone with overall 
e­GFRs are probably not sensitive enough to detect loss of function 
in individual kidneys.
The commonest procedure performed was PTA, which was done 
in half of the patients, either singly or in combination with other 
revascularisation procedures. Studies have shown good success both 
technically and clinically using PTA in children with Takayasu’s 
arteritis,[11,30­32] as well as in those without.[18,22,23,33,34] However, only 
Chalmers et al.[18] and Huang et al.[22] reported on renal function, 
and with good outcomes. One of the complications reported in the 
studies in which PTA was carried out is restenosis, the rates of which 
vary between different reports. While the underlying diagnosis 
may well play a role in this complication, the site and nature of the 
stenosis, the techniques used and the decision whether or not to 
insert a stent vary in these reports, making comparison of success 
rates difficult. Surgical revascularisation has been shown to have a 
better outcome than PTA in adult patients with Takayasu’s arteritis 
in terms of patency rates and postoperative complications.[27,35,36] 
A recent paediatric report from the USA which included patients 
with Takayasu’s arteritis also showed a higher rate of reintervention 
with PTA compared with surgery.[23] Despite the slightly higher 
complication rate, many authors would still recommend PTA as the 
first choice where possible in children.[20,30,32] This is because PTA 
may be possible when children are too small to be operated on. PTA 
is a simple, cost­effective procedure, and is an attractive option in 
developing countries where vascular surgeons may not be available. 
Advancing endovascular techniques such as cutting wires, high­
pressure balloons and different types of stents may further contribute 
to the increasing use of PTA in the future.[23,33]
Two of our patients had an arterial bypass using the saphenous 
vein. Although there have been reports of aneurysmal dilatation 
with this approach,[24] a recent report from China showed a very 
good outcome in children with Takayasu’s arteritis­induced 
renovascular hypertension in terms of hypertension and function. [21] 
Revascularisation using other arteries, such as spleno­renal, 
gastroduodenal­renal, hepato­renal and ilio­renal bypass surgery, 
has been documented to have a high restenosis rate. In our series, 
although the bypass surgeries were not successful in controlling 
hypertension,[11] we were able to preserve renal function.
Study limitations
This study was a retrospective review of data spanning over two 
decades. This proved to be a limitation, as during this period there 
was considerable evolution of management protocols, both medical 
and surgical, as well as advances in interventional techniques and 
technology. In addition, the diagnostic criteria for the classification 
of childhood vasculitides have evolved over time, and have been 
adopted by EULAR/PReS.[12] These criteria are nonspecific, and it 
is possible that a few patients with other diagnoses may have been 
included in our study.
Conclusion
Renal revascularisation in children with Takayasu’s arteritis can yield 
a significant benefit in long­term renal function. It may be impor­
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tant to consider the procedure before the patient develops significant 
renal dysfunction, after which this benefit may be much reduced. The 
retrospective nature of our study, which invariably implies lost data, 
the lack of serial nuclear GFRs of the patients, and the small number 
of patients studied could be limitations.
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